These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 22362893)

  • 1. Thrombospondin-4 regulates fibrosis and remodeling of the myocardium in response to pressure overload.
    Frolova EG; Sopko N; Blech L; Popovic ZB; Li J; Vasanji A; Drumm C; Krukovets I; Jain MK; Penn MS; Plow EF; Stenina OI
    FASEB J; 2012 Jun; 26(6):2363-73. PubMed ID: 22362893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombospondin-4 mediates cardiovascular remodelling in angiotensin II-induced hypertension.
    Palao T; Medzikovic L; Rippe C; Wanga S; Al-Mardini C; van Weert A; de Vos J; van der Wel NN; van Veen HA; van Bavel ET; Swärd K; de Waard V; Bakker EN
    Cardiovasc Pathol; 2018; 35():12-19. PubMed ID: 29729633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous thrombospondin 1 protects the pressure-overloaded myocardium by modulating fibroblast phenotype and matrix metabolism.
    Xia Y; Dobaczewski M; Gonzalez-Quesada C; Chen W; Biernacka A; Li N; Lee DW; Frangogiannis NG
    Hypertension; 2011 Nov; 58(5):902-11. PubMed ID: 21947471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.
    Matsusaka H; Ide T; Matsushima S; Ikeuchi M; Kubota T; Sunagawa K; Kinugawa S; Tsutsui H
    Hypertension; 2006 Apr; 47(4):711-7. PubMed ID: 16505197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombospondin-4 knockout in hypertension protects small-artery endothelial function but induces aortic aneurysms.
    Palao T; Rippe C; van Veen H; VanBavel E; Swärd K; Bakker EN
    Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1486-93. PubMed ID: 26968543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure.
    Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R
    Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
    Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
    J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moderate Loss of the Extracellular Matrix Proteoglycan Lumican Attenuates Cardiac Fibrosis in Mice Subjected to Pressure Overload.
    Mohammadzadeh N; Melleby AO; Palmero S; Sjaastad I; Chakravarti S; Engebretsen KVT; Christensen G; Lunde IG; Tønnessen T
    Cardiology; 2020; 145(3):187-198. PubMed ID: 31968347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extracellular matrix proteoglycan fibromodulin is upregulated in clinical and experimental heart failure and affects cardiac remodeling.
    Andenæs K; Lunde IG; Mohammadzadeh N; Dahl CP; Aronsen JM; Strand ME; Palmero S; Sjaastad I; Christensen G; Engebretsen KVT; Tønnessen T
    PLoS One; 2018; 13(7):e0201422. PubMed ID: 30052659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload.
    Fliegner D; Schubert C; Penkalla A; Witt H; Kararigas G; Dworatzek E; Staub E; Martus P; Ruiz Noppinger P; Kintscher U; Gustafsson JA; Regitz-Zagrosek V
    Am J Physiol Regul Integr Comp Physiol; 2010 Jun; 298(6):R1597-606. PubMed ID: 20375266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of Microfibrillar-Associated Protein 4 Attenuates Left Ventricular Remodeling and Dysfunction in Heart Failure.
    Wang HB; Yang J; Shuai W; Yang J; Liu LB; Xu M; Tang QZ
    J Am Heart Assoc; 2020 Sep; 9(17):e015307. PubMed ID: 32856514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation.
    Gonzalez-Quesada C; Cavalera M; Biernacka A; Kong P; Lee DW; Saxena A; Frunza O; Dobaczewski M; Shinde A; Frangogiannis NG
    Circ Res; 2013 Dec; 113(12):1331-44. PubMed ID: 24081879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2.
    Wang H; Lai Y; Mathis BJ; Wang W; Li S; Qu C; Li B; Shao L; Song H; Janicki JS; Sun SC; Wang XL; Tang D; Cui T
    J Mol Cell Cardiol; 2015 Jul; 84():143-53. PubMed ID: 25935309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of thrombospondin-2 reduces fibrosis and increases vascularity around cardiac cell grafts.
    Reinecke H; Robey TE; Mignone JL; Muskheli V; Bornstein P; Murry CE
    Cardiovasc Pathol; 2013; 22(1):91-5. PubMed ID: 22512900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of transforming growth factor-beta1 reflect left ventricular remodeling in aortic stenosis.
    Villar AV; Cobo M; Llano M; Montalvo C; González-Vílchez F; Martín-Durán R; Hurlé MA; Nistal JF
    PLoS One; 2009 Dec; 4(12):e8476. PubMed ID: 20041033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial S1pr1 regulates pressure overload-induced cardiac remodelling through AKT-eNOS pathway.
    Liu X; Wu J; Zhu C; Liu J; Chen X; Zhuang T; Kuang Y; Wang Y; Hu H; Yu P; Fan H; Zhang Y; Liu Z; Zhang L
    J Cell Mol Med; 2020 Jan; 24(2):2013-2026. PubMed ID: 31854513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-calcitonin gene-related peptide is protective against pressure overload-induced heart failure.
    Li J; Levick SP; DiPette DJ; Janicki JS; Supowit SC
    Regul Pept; 2013 Aug; 185():20-8. PubMed ID: 23816470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
    Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
    Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-33 Controls Adaptive Fibrotic Response in the Remodeling Heart by Preserving Lipid Raft Cholesterol.
    Nishiga M; Horie T; Kuwabara Y; Nagao K; Baba O; Nakao T; Nishino T; Hakuno D; Nakashima Y; Nishi H; Nakazeki F; Ide Y; Koyama S; Kimura M; Hanada R; Nakamura T; Inada T; Hasegawa K; Conway SJ; Kita T; Kimura T; Ono K
    Circ Res; 2017 Mar; 120(5):835-847. PubMed ID: 27920122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTGF knockout does not affect cardiac hypertrophy and fibrosis formation upon chronic pressure overload.
    Fontes MS; Kessler EL; van Stuijvenberg L; Brans MA; Falke LL; Kok B; Leask A; van Rijen HV; Vos MA; Goldschmeding R; van Veen TA
    J Mol Cell Cardiol; 2015 Nov; 88():82-90. PubMed ID: 26410398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.